May 21st, 2014
The Risk-Prediction Conundrum: Individual Risk vs. Population Risk
John W McEvoy, MB BCh BAO
John W. McEvoy discusses his recent review article about how to interpret cardiac risk for an individual patient when risk estimates are more accurate for populations of patients.
June 6th, 2012
Selections from Richard Lehman’s Literature Review: June 6th
Richard Lehman, BM, BCh, MRCGP
This week’s topics include cIMT and clinical outcome, CVD risk scores, door- vs. onset-to-balloon times, and dark chocolate consumption in people with high CVD risk.
NEJM Journal Watch — Recent Cardiology Articles- Anticoagulation in Patients with Cancer-Associated Pulmonary Embolism: How Long is Long Enough?
- Spironolactone Use After Percutaneous Intervention for Acute Myocardial Infarction
- CRISPR/Cas9 Gene Editing for Transthyretin Cardiomyopathy
- Does Colchicine Reduce Cardiac Events After Myocardial Infarction?
- First-Line Therapy for Ventricular Tachycardia After MI: What's the Best Approach?